[Expression and Significance of Low-Density Lipoprotein-Related Receptors 5 and 6 in the Wnt/β-Catenin Signaling Pathway in Childhood Acute Lymphoblastic Leukemia]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):433-438. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.020.
[Article in Chinese]

Abstract

Objective: To investigate the significance of low-density lipoprotein receptor-related protein 5 and 6 (LRP5/6) in the Wnt/β-catenin signaling pathway in the pathogenesis and prognosis of childhood acute lymphoblastic leukemia (ALL).

Methods: A total of 43 children who were newly diagnosed and achieved complete remission after remission induction therapy were enrolled. The children before treatment were included in incipient group, and after treatment when achieved complete remission included in remission group. A total of 39 children with immune thrombocytopenia were enrolled in control group. Three milliliter bone marrow samples were collected from above-mentioned each group. QRT-PCR was used to determine the mRNA expression of LRP5 and LRP6 in blood mononuclear cells of bone marrow. Western blot was used to detect the protein expression of LRP5 and LRP6. According to the protein expression levels of LRP5 and LRP6, the children were divided into low-expression group and high-expression group, and the clinical biological characteristics were compared between these two groups. Survival analysis was performed by Kaplan-Meier method.

Results: Both mRNA and protein expression levels of LRP5 and 6 were upregulated in the incipient group compared with the control and remission group (P<0.05). The mRNA and protein expressions of LRP5 and LRP6 in the high-risk group were higher than those in the medium-risk group (P<0.05), it is the same as in the medium-risk group than the low-risk group (P<0.05). The mRNA and protein expressions of LRP5 and 6 positively correlated with risk degree in the incipient group (rLRP5 mRNA=0.84, P<0.05; rLRP6 mRNA=0.66, P<0.05; rLRP5 protein=0.82, P<0.05; rLRP6 protein=0.76, P<0.05). The white blood cell count and lactate dehydrogenase in LRP5 and LRP6 high expression group were significantly higher than those in low expression group (P<0.05), while there was no significant difference in other biological characteristics. Kaplan-meier survival analysis showed that in the 43 children 3-year overall survival rate and event-free survival rate was (91.7±4.7)% and (87.6±5.2)%, respectively.

Conclusion: The high expression of LRP5/6 may be one of the pathogenesis of childhood ALL, and the degree of LRP5/6 increase may be related to the risk level.

题目: Wnt/β-catenin通路中LRP5/6在儿童急性淋巴细胞白血病中的表达及意义.

目的: 探讨Wnt/β-catenin信号通路中低密度脂蛋白受体相关蛋白5/6(LRP5/6)在儿童急性淋巴细胞白血病(ALL)中的表达及意义.

方法: 选取初发且诱导缓解治疗后达完全缓解的ALL患儿43例,治疗前作为初发组,诱导治疗后完全缓解时作为缓解组,另选取39例免疫性血小板减少症患儿作为对照组。采集初发组、缓解组、对照组患儿骨髓血各3 ml,采用qRT-PCR法检测骨髓血单个核细胞中LRP5和LRP6 mRNA的表达,Western blot法检测LRP5和LRP6蛋白的表达。依据LRP5、LRP6蛋白的表达水平,将患儿分为低表达组和高表达组,比较两组患儿的临床生物学特征。Kaplan-Meier法进行生存分析.

结果: 初发组LRP5、LRP6 mRNA及蛋白的表达水平均明显高于缓解组及对照组(P<0.05),高危组患儿的LRP5、LRP6 mRNA及蛋白表达均明显高于中危组(P<0.05),中危组LRP5、LRP6 mRNA及蛋白表达均明显高于低危组(P<0.05)。初发组中LRP5、LRP6 mRNA及蛋白表达与危险度呈正相关(rLRP5 mRNA=0.84,P<0.05;rLRP6 mRNA=0.66,P<0.05;rLRP5 protein=0.82,P<0.05;rLRP6 protein=0.76,P<0.05)。LRP5及LRP6高表达组初发白细胞计数、乳酸脱氢酶水平显著高于低表达组(P<0.05),而其他生物学特征无明显差异。Kaplan-Meier生存分析显示43例患儿3年总生存率为(91.7±4.7)%,3年无事件生存率为(87.6±5.2).

结论: LRP5/6高表达是儿童ALL发病机制之一,其增高程度与危险度有关.

MeSH terms

  • Child
  • Humans
  • Lipoproteins, LDL
  • Low Density Lipoprotein Receptor-Related Protein-5
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*
  • Receptors, LDL
  • Wnt Signaling Pathway*
  • beta Catenin / metabolism

Substances

  • Lipoproteins, LDL
  • Low Density Lipoprotein Receptor-Related Protein-5
  • Receptors, LDL
  • beta Catenin